Drug therapy problems for patients with tuberculosis and HIV/AIDS at a reference hospital.
Natália Helena de ResendeSilvana Spindola de MirandaMaria das Graças Braga CeccatoJoão Paulo Amaral HaddadAdriano Max Moreira ReisDirce Inês da SilvaWânia da Silva CarvalhoPublished in: Einstein (Sao Paulo, Brazil) (2019)
The frequency of drug therapy problem in coinfected patients was high and the identification of the main drug therapy problem and associated factors may lead the multiprofessional health team to ensure the use of the most indicated, effective, safe and convenient medicines for the patients clinical condition. Tuberculosis and HIV/AIDS coinfected individuals aged over 40 years are more likely to have drug therapy problems during treatment; in that, the most frequente are those that signal toward need of medication for an untreated health condition and non-compliance to treatment. Thus, older patients, unmarried or married, who have treated tuberculosis before, with a shorter time to tuberculosis treatment and longer time to diagnose HIV/AIDS, should receive special attention and be better followed by a multiprofessional health team because they indicate a higher chance of presenting Problems related to the use of non-adherent drugs.
Keyphrases
- hiv aids
- mental health
- antiretroviral therapy
- healthcare
- end stage renal disease
- adverse drug
- public health
- newly diagnosed
- human immunodeficiency virus
- ejection fraction
- mycobacterium tuberculosis
- chronic kidney disease
- prognostic factors
- health information
- peritoneal dialysis
- hiv infected
- pulmonary tuberculosis
- bone marrow
- cell therapy
- case report
- mesenchymal stem cells
- replacement therapy
- health promotion
- combination therapy